olfactory receptor family 51 subfamily B member 8 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR51B8P profile across patient tissues and cancer cell-line models. OR51B8P expression is associated with patient survival in 11 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, OR51B8P is differentially expressed in 1, with the highest sampling consensus in KIRC. Additionally, OR51B8P RNA expression shows 6,496 significant gene co-expression associations, with the highest sampling consensus in COAD. Together, these results highlight COAD, and KIRC as cancer lineages where OR51B8P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR51B8P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR51B8P survival associations across molecular data types. OR51B8P RNA expression shows survival associations in the most cancer types (11). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR51B8P RNA expression–survival associations across cancer types. High OR51B8P expression shows unfavorable associations in COAD, LIHC, BLCA and OV, but favorable associations in SKCM and GBM. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify COAD as the clearest survival context for OR51B8P RNA expression.
This table summarizes OR51B8P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KIRC for RNA.
This table ranks reproducible tumor–normal expression differences for OR51B8P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR51B8P shows higher tumor expression in KIRC. The KIRC box plot shows higher OR51B8P RNA expression in tumor versus normal tissue (log2 FC = +0.009, t-test p = .041).
This table shows molecular features associated with OR51B8P in patient tissues and cancer cell lines. In patient samples, OR51B8P shows the broadest associations at the RNA and protein expression levels, with COAD recurring as the lineage with the largest associated feature set.
